 Nausica Arnoult
Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Breaks, Double-Stranded | 7 | 2026 | 55 | 4.350 |
Why?
| | Telomere | 17 | 2026 | 287 | 4.020 |
Why?
| | DNA Repair | 5 | 2026 | 255 | 3.510 |
Why?
| | DNA End-Joining Repair | 5 | 2026 | 22 | 2.050 |
Why?
| | Poly(ADP-ribose) Polymerases | 2 | 2026 | 88 | 1.780 |
Why?
| | Poly (ADP-Ribose) Polymerase-1 | 2 | 2026 | 53 | 1.760 |
Why?
| | Heterochromatin | 3 | 2026 | 66 | 1.080 |
Why?
| | Promyelocytic Leukemia Protein | 2 | 2026 | 5 | 0.970 |
Why?
| | DNA Replication | 7 | 2025 | 249 | 0.970 |
Why?
| | Epistasis, Genetic | 1 | 2026 | 64 | 0.910 |
Why?
| | Radiation, Ionizing | 1 | 2026 | 86 | 0.900 |
Why?
| | Telomerase | 6 | 2024 | 246 | 0.870 |
Why?
| | Telomere-Binding Proteins | 4 | 2020 | 119 | 0.790 |
Why?
| | DNA Damage | 1 | 2026 | 437 | 0.750 |
Why?
| | DNA | 7 | 2025 | 1437 | 0.740 |
Why?
| | Chromosomal Proteins, Non-Histone | 3 | 2026 | 130 | 0.670 |
Why?
| | S Phase | 4 | 2025 | 78 | 0.660 |
Why?
| | G2 Phase | 1 | 2017 | 39 | 0.520 |
Why?
| | Recombinational DNA Repair | 1 | 2017 | 19 | 0.520 |
Why?
| | Recombination, Genetic | 2 | 2014 | 205 | 0.460 |
Why?
| | DNA Repair Enzymes | 1 | 2015 | 29 | 0.460 |
Why?
| | RNA, Untranslated | 3 | 2013 | 121 | 0.440 |
Why?
| | Telomere Homeostasis | 3 | 2026 | 33 | 0.430 |
Why?
| | Poly(ADP-ribose) Polymerase Inhibitors | 3 | 2026 | 133 | 0.430 |
Why?
| | Chromosome Pairing | 1 | 2014 | 11 | 0.430 |
Why?
| | Chromatin | 5 | 2025 | 553 | 0.410 |
Why?
| | Mammals | 1 | 2015 | 286 | 0.410 |
Why?
| | Ku Autoantigen | 2 | 2026 | 11 | 0.370 |
Why?
| | Histone-Lysine N-Methyltransferase | 2 | 2024 | 141 | 0.370 |
Why?
| | RecQ Helicases | 2 | 2020 | 9 | 0.350 |
Why?
| | Gene Silencing | 1 | 2012 | 202 | 0.340 |
Why?
| | Histones | 2 | 2014 | 666 | 0.320 |
Why?
| | Cytosine | 1 | 2009 | 49 | 0.300 |
Why?
| | Exodeoxyribonucleases | 1 | 2009 | 23 | 0.300 |
Why?
| | Molecular Chaperones | 2 | 2026 | 199 | 0.290 |
Why?
| | Cell Nucleus | 2 | 2025 | 588 | 0.290 |
Why?
| | Oxazoles | 1 | 2009 | 48 | 0.290 |
Why?
| | Ovarian Neoplasms | 2 | 2024 | 595 | 0.270 |
Why?
| | Nuclear Proteins | 4 | 2026 | 740 | 0.260 |
Why?
| | Cell Line | 7 | 2017 | 2823 | 0.250 |
Why?
| | X-linked Nuclear Protein | 1 | 2026 | 8 | 0.240 |
Why?
| | MRE11 Homologue Protein | 1 | 2026 | 5 | 0.240 |
Why?
| | Co-Repressor Proteins | 1 | 2026 | 18 | 0.240 |
Why?
| | Mitosis | 2 | 2026 | 193 | 0.230 |
Why?
| | Humans | 23 | 2026 | 145750 | 0.230 |
Why?
| | Phthalazines | 1 | 2026 | 63 | 0.220 |
Why?
| | CRISPR-Cas Systems | 1 | 2026 | 166 | 0.210 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2026 | 194 | 0.210 |
Why?
| | Cell Line, Tumor | 9 | 2024 | 3551 | 0.200 |
Why?
| | DNA Helicases | 1 | 2025 | 136 | 0.200 |
Why?
| | Endonucleases | 1 | 2023 | 34 | 0.190 |
Why?
| | Piperazines | 1 | 2026 | 375 | 0.190 |
Why?
| | Homologous Recombination | 1 | 2023 | 37 | 0.190 |
Why?
| | Animals | 10 | 2026 | 38100 | 0.180 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2024 | 883 | 0.180 |
Why?
| | In Situ Hybridization, Fluorescence | 3 | 2009 | 328 | 0.150 |
Why?
| | G1 Phase | 2 | 2017 | 65 | 0.150 |
Why?
| | Mice | 6 | 2026 | 18357 | 0.140 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2024 | 1450 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2024 | 923 | 0.140 |
Why?
| | Chromatids | 1 | 2017 | 10 | 0.130 |
Why?
| | Chromosome Aberrations | 1 | 2017 | 166 | 0.120 |
Why?
| | Protein Binding | 2 | 2025 | 2240 | 0.120 |
Why?
| | Neoplasms | 3 | 2020 | 2913 | 0.110 |
Why?
| | Methylation | 2 | 2014 | 242 | 0.110 |
Why?
| | DNA Methylation | 2 | 2012 | 690 | 0.110 |
Why?
| | HeLa Cells | 3 | 2025 | 632 | 0.110 |
Why?
| | RNA-Binding Proteins | 2 | 2020 | 447 | 0.100 |
Why?
| | Transcriptome | 1 | 2020 | 1043 | 0.100 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2014 | 79 | 0.100 |
Why?
| | Gorilla gorilla | 1 | 2013 | 17 | 0.100 |
Why?
| | Pan troglodytes | 1 | 2013 | 62 | 0.090 |
Why?
| | Cell Cycle | 3 | 2014 | 599 | 0.090 |
Why?
| | Fibroblasts | 3 | 2020 | 1027 | 0.090 |
Why?
| | RNA, Messenger | 1 | 2020 | 2805 | 0.090 |
Why?
| | DNA, Satellite | 1 | 2012 | 18 | 0.090 |
Why?
| | Base Sequence | 2 | 2012 | 2171 | 0.090 |
Why?
| | Methyltransferases | 1 | 2012 | 75 | 0.090 |
Why?
| | Heat-Shock Response | 1 | 2012 | 77 | 0.090 |
Why?
| | Werner Syndrome Helicase | 1 | 2009 | 3 | 0.080 |
Why?
| | Down-Regulation | 1 | 2012 | 618 | 0.080 |
Why?
| | RNA | 2 | 2013 | 912 | 0.080 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2012 | 337 | 0.080 |
Why?
| | Cell Cycle Proteins | 1 | 2014 | 630 | 0.080 |
Why?
| | Chromosomes | 1 | 2010 | 106 | 0.080 |
Why?
| | Telomeric Repeat Binding Protein 2 | 2 | 2025 | 8 | 0.070 |
Why?
| | Guanine | 1 | 2009 | 85 | 0.070 |
Why?
| | Sister Chromatid Exchange | 1 | 2009 | 4 | 0.070 |
Why?
| | Metaphase | 1 | 2009 | 33 | 0.070 |
Why?
| | Repressor Proteins | 1 | 2012 | 429 | 0.070 |
Why?
| | Replication Origin | 1 | 2008 | 18 | 0.070 |
Why?
| | Nucleic Acid Hybridization | 1 | 2009 | 187 | 0.070 |
Why?
| | Cell Division | 1 | 2009 | 757 | 0.060 |
Why?
| | Tumor Suppressor Proteins | 1 | 2009 | 322 | 0.060 |
Why?
| | Cell Proliferation | 2 | 2025 | 2514 | 0.060 |
Why?
| | Movement | 1 | 2008 | 293 | 0.060 |
Why?
| | Histocompatibility Antigens | 1 | 2024 | 102 | 0.050 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 2014 | 117 | 0.050 |
Why?
| | Transcription, Genetic | 3 | 2014 | 1454 | 0.050 |
Why?
| | Transcription Factors | 1 | 2009 | 1736 | 0.040 |
Why?
| | Female | 3 | 2024 | 79025 | 0.040 |
Why?
| | Granulocyte Precursor Cells | 1 | 2020 | 9 | 0.040 |
Why?
| | Aurora Kinases | 1 | 2020 | 28 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2024 | 936 | 0.040 |
Why?
| | Chromosomes, Mammalian | 1 | 2020 | 28 | 0.040 |
Why?
| | Mouse Embryonic Stem Cells | 1 | 2020 | 36 | 0.040 |
Why?
| | Gene Regulatory Networks | 1 | 2020 | 319 | 0.030 |
Why?
| | Monocytes | 1 | 2020 | 539 | 0.030 |
Why?
| | Computational Biology | 1 | 2020 | 669 | 0.030 |
Why?
| | Gene Expression Regulation | 2 | 2014 | 2601 | 0.030 |
Why?
| | Protein Stability | 1 | 2014 | 176 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2024 | 4569 | 0.020 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2014 | 155 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2013 | 334 | 0.020 |
Why?
| | Hominidae | 1 | 2013 | 87 | 0.020 |
Why?
| | Heat-Shock Proteins | 1 | 2012 | 139 | 0.020 |
Why?
| | RNA Interference | 1 | 2013 | 475 | 0.020 |
Why?
| | Neurons | 1 | 2020 | 1652 | 0.020 |
Why?
| | Kinetics | 1 | 2014 | 1568 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2013 | 731 | 0.020 |
Why?
| | Intranuclear Space | 1 | 2009 | 1 | 0.020 |
Why?
| | Fluorescent Antibody Technique, Indirect | 1 | 2009 | 45 | 0.020 |
Why?
| | Models, Molecular | 1 | 2014 | 1599 | 0.020 |
Why?
| | DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2009 | 16 | 0.020 |
Why?
| | DNA (Cytosine-5-)-Methyltransferases | 1 | 2009 | 36 | 0.020 |
Why?
| | Nuclear Matrix | 1 | 2008 | 6 | 0.020 |
Why?
| | Cricetulus | 1 | 2008 | 118 | 0.020 |
Why?
| | Cricetinae | 1 | 2008 | 305 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2012 | 2883 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2012 | 693 | 0.020 |
Why?
| | Proteomics | 1 | 2013 | 1188 | 0.020 |
Why?
| | Biomarkers, Tumor | 1 | 2012 | 1329 | 0.010 |
Why?
| | Time Factors | 1 | 2008 | 7133 | 0.010 |
Why?
|
|
Arnoult's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|